Compare Abeona Therapeutics Inc (ABEO) vs Vistra Corp (VST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Vistra Corp — how do they compare? Abeona Therapeutics Inc trades at $7.46 (market cap $421.19M), while Vistra Corp trades at $145.61 (market cap $48.64B). The key difference: Vistra Corp is far larger — about 115.5× Abeona Therapeutics Inc's market cap, and Vistra Corp pays a 0.63% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | VST | |
|---|---|---|
Market Cap | $421.19M | $48.64B |
Sector | Health | Technology |
52-Week High | $7.45 | $217.92 |
52-Week Low | $4.17 | $134.71 |
Enterprise Value | $276.10M | $70.58B |
Dividend Yield | — | 0.63% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Vistra Corp
Vistra is a leading integrated retail electricity and power generation company that serves as a critical infrastructure provider for the digital economy. It operates a diversified portfolio of zero-carbon nuclear and renewable assets alongside a massive, flexible natural gas fleet, positioning it as an indispensable partner for energy-intensive AI data centers and industrial electrification.
Read more on VST →
